STATCenter·
STAT+: GSK picks up hep B drug approval
GSK has won FDA approval for its hepatitis B drug, which extended functional cures to far more patients than previous methods.
Read at STAT →
Health · 1 sources covering this
STAT+: GSK picks up hep B drug approval
GSK has won FDA approval for its hepatitis B drug, which extended functional cures to far more patients than previous methods.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/013a643b095d59c3d55ce4bd032bfa5bce03db14" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: GSK picks up hep B drug approval"></iframe>
